SPARSH BIOTECH is rapidly establishing itself as a significant player in the pharmaceutical sector, especially recognized for its cutting-edge process of creating Amoxicilline and Augmentin. The firm boasts state-of-the-art plants and a committed team ensuring superior drugs benefiting patients internationally. Via stric